Siddharth Sitaram Sells 2,077 Shares of Doximity (NYSE:DOCS) Stock

Doximity, Inc. (NYSE:DOCS) CAO Siddharth Sitaram sold 2,077 shares of the stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $26.02, for a total transaction of $54,043.54. Following the transaction, the chief accounting officer directly owned 96,045 shares in the company, valued at approximately $2,499,090.90. This represents a 2.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Thursday, August 13th, Siddharth Sitaram sold 1,770 shares of Doximity stock. The stock was sold at an average price of $24.94, for a total value of $44,143.80.

Doximity Stock Up 2.4%

DOCS opened at $26.56 on Friday. Doximity, Inc. has a 52-week low of $17.15 and a 52-week high of $76.51. The company has a market cap of $4.73 billion, a P/E ratio of 31.24, a P/E/G ratio of 20.29 and a beta of 1.25. The company has a 50 day moving average of $24.00 and a two-hundred day moving average of $23.13.

Doximity (NYSE:DOCS) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.13. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The company had revenue of $156.62 million during the quarter. During the same period last year, the business earned $0.36 EPS. The firm’s revenue was up 7.3% compared to the same quarter last year. Research analysts anticipate that Doximity, Inc. will post 0.74 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on DOCS. JPMorgan Chase & Co. raised their target price on shares of Doximity from $26.00 to $31.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Evercore set a $40.00 price target on Doximity in a research report on Friday, August 7th. Stifel Nicolaus set a $27.00 price target on Doximity in a report on Tuesday, September 8th. Freedom Capmkts lowered Doximity from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 8th. Finally, Barclays boosted their price objective on Doximity from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Friday, August 21st. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $32.18.

Institutional Investors Weigh In On Doximity

Several institutional investors have recently bought and sold shares of DOCS. Tidal Investments LLC grew its position in Doximity by 207.9% in the 2nd quarter. Tidal Investments LLC now owns 43,761 shares of the company’s stock valued at $908,000 after buying an additional 29,546 shares in the last quarter. Engineers Gate Manager LP raised its position in shares of Doximity by 15.9% during the 2nd quarter. Engineers Gate Manager LP now owns 285,198 shares of the company’s stock worth $5,915,000 after buying an additional 39,223 shares in the last quarter. RFG Advisory LLC bought a new stake in shares of Doximity during the 2nd quarter worth about $1,161,000. Nykredit A S acquired a new stake in shares of Doximity in the 2nd quarter worth approximately $96,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Doximity in the 2nd quarter worth approximately $1,515,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

• Neutral Sentiment: Doximity’s chief accounting officer sold 2,077 shares for approximately $54,044 under a pre-arranged Rule 10b5-1 plan. The filing said the sale was intended to cover tax-withholding obligations tied to vested equity awards, making it a limited signal of management’s view of the company’s prospects. Doximity CAO stock sale
• Neutral Sentiment: The company’s latest reported quarter showed adjusted strength, with earnings of $0.29 per share versus analysts’ $0.16 consensus and revenue of $156.6 million, up 7.3% year over year. Analysts’ average price target remains above the current trading level, but the consensus rating is Hold. These results provide some fundamental support, although they are not new developments from the past day. Doximity financial and analyst information
• Negative Sentiment: Several law firms announced or promoted a securities class action filed against Doximity and certain current and former executives. The lawsuit covers investors who purchased DOCS shares from August 8, 2024, through May 13, 2026, and alleges violations of federal securities laws and investor harm. Investors seeking lead-plaintiff status generally face a November 16, 2026 deadline. The allegations have not been proven, but the legal uncertainty could pressure sentiment and potentially expose Doximity to litigation costs or damages. Doximity securities class action announcement

Doximity Company Profile

Doximity, Inc operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients.

The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform.

Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market.